Table 4—

Prevalence of self-reported heart attack, stroke, and congestive heart failure by metabolic syndrome status defined by the ATP III and WHO among U.S. adults aged ≥20 years (NHANES III, 1988–1994)

Metabolic syndrome
No metabolic syndrome
PSample sizeOdds ratio*
Sample sizeAge-adjusted prevalenceSample sizeAge-adjusted prevalence
ATP III
 Heart attack2,2094.5 ± 0.66,3132.9 ± 0.30.0178,3721.59 (1.12–2.25)
 Stroke2,2163.0 ± 0.66,3891.3 ± 0.20.0088,4552.39 (1.40–4.09)
 Congestive heart failure2,2103.1 ± 0.66,3871.8 ± 0.30.0568,4461.81 (1.06–3.10)
WHO
 Heart attack2,5155.1 ± 0.66,0072.6 ± 0.3<0.0018,3722.03 (1.41–2.91)
 Stroke2,5352.8 ± 0.46,0701.3 ± 0.2<0.0018,4552.17 (1.47–3.22)
 Congestive heart failure2,5283.6 ± 0.66,0691.5 ± 0.20.0028,4462.53 (1.50–4.26)
  • Data are n, % ± SE, or OR (95% CI).

  • *

    * Odds ratio is adjusted for age, sex, race or ethnicity, education, smoking status, cotinine concentration, and non-HDL cholesterol concentration.